Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Agustin Calatroni

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
Plos Genetics|January 13, 2023
Multi-omic association study identifies DNA methylation-mediated genotype and smoking exposure effects on lung function in children living in urban settingsMatthew Dapas, Emma E Thompson, William Wentworth-Sheilds, et al.
JAMA Network Open|February 28, 2024
Early-Life Exposure to Air Pollution and Childhood Asthma Cumulative Incidence in the ECHO CREW ConsortiumAntonella Zanobetti, Patrick H Ryan, Brent A Coull, et al.
The Journal of Allergy and Clinical Immunology|February 12, 2022
Seasonal airway microbiome and transcriptome interactions promote childhood asthma exacerbationsKathryn E McCauley, Kaitlin Flynn, Agustin Calatroni, et al.
The Journal of Allergy and Clinical Immunology|May 8, 2024
A pediatric randomized, controlled trial of German cockroach subcutaneous immunotherapyEdward Zoratti, Robert Wood, Anna Pomés, et al.
Preventive Medicine Reports|December 19, 2024
Caregiver worry about COVID-19 as a predictor of social mitigation behaviours and SARS-CoV-2 infection in a 12-city U.S. surveillance study of households with childrenSteven M Brunwasser, Tebeb Gebretsadik, Anisha Satish, et al.
Lancet (London, England)|August 14, 2022
Mepolizumab for urban children with exacerbation-prone eosinophilic asthma in the USA (MUPPITS-2): a randomised, double-blind, placebo-controlled, parallel-group trialDaniel J Jackson, Leonard B Bacharier, Peter J Gergen, et al.
The Journal of Allergy and Clinical Immunology|July 27, 2025
Cockroach immunotherapy modulates dominant T-cell responses independent of allergen extract contentRicardo da Silva Antunes, Aaron Sutherland, Adam Abawi, et al.
The New England Journal of Medicine|February 26, 2024
Omalizumab for the Treatment of Multiple Food AllergiesRobert A Wood, Alkis Togias, Scott H Sicherer, et al.
The Journal of Allergy and Clinical Immunology|June 6, 2022
Risk factors for SARS-CoV-2 infection and transmission in households with children with asthma and allergy: A prospective surveillance studyMax A Seibold, Camille M Moore, Jamie L Everman, et al.
Medrxiv : the Preprint Server for Health Sciences|July 21, 2022
Human Epidemiology and RespOnse to SARS-CoV-2 (HEROS): Objectives, Design and Enrollment Results of a 12-City Remote Observational Surveillance Study of Households with Children using Direct-to-Participant MethodsPatricia C Fulkerson, Stephanie J Lussier, Casper G Bendixsen, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Plos Genetics|January 13, 2023
Multi-omic association study identifies DNA methylation-mediated genotype and smoking exposure effects on lung function in children living in urban settingsMatthew Dapas, Emma E Thompson, William Wentworth-Sheilds, et al.
JAMA Network Open|February 28, 2024
Early-Life Exposure to Air Pollution and Childhood Asthma Cumulative Incidence in the ECHO CREW ConsortiumAntonella Zanobetti, Patrick H Ryan, Brent A Coull, et al.
The Journal of Allergy and Clinical Immunology|February 12, 2022
Seasonal airway microbiome and transcriptome interactions promote childhood asthma exacerbationsKathryn E McCauley, Kaitlin Flynn, Agustin Calatroni, et al.
The Journal of Allergy and Clinical Immunology|May 8, 2024
A pediatric randomized, controlled trial of German cockroach subcutaneous immunotherapyEdward Zoratti, Robert Wood, Anna Pomés, et al.
Preventive Medicine Reports|December 19, 2024
Caregiver worry about COVID-19 as a predictor of social mitigation behaviours and SARS-CoV-2 infection in a 12-city U.S. surveillance study of households with childrenSteven M Brunwasser, Tebeb Gebretsadik, Anisha Satish, et al.
Lancet (London, England)|August 14, 2022
Mepolizumab for urban children with exacerbation-prone eosinophilic asthma in the USA (MUPPITS-2): a randomised, double-blind, placebo-controlled, parallel-group trialDaniel J Jackson, Leonard B Bacharier, Peter J Gergen, et al.
The Journal of Allergy and Clinical Immunology|July 27, 2025
Cockroach immunotherapy modulates dominant T-cell responses independent of allergen extract contentRicardo da Silva Antunes, Aaron Sutherland, Adam Abawi, et al.
The New England Journal of Medicine|February 26, 2024
Omalizumab for the Treatment of Multiple Food AllergiesRobert A Wood, Alkis Togias, Scott H Sicherer, et al.
The Journal of Allergy and Clinical Immunology|June 6, 2022
Risk factors for SARS-CoV-2 infection and transmission in households with children with asthma and allergy: A prospective surveillance studyMax A Seibold, Camille M Moore, Jamie L Everman, et al.
Medrxiv : the Preprint Server for Health Sciences|July 21, 2022
Human Epidemiology and RespOnse to SARS-CoV-2 (HEROS): Objectives, Design and Enrollment Results of a 12-City Remote Observational Surveillance Study of Households with Children using Direct-to-Participant MethodsPatricia C Fulkerson, Stephanie J Lussier, Casper G Bendixsen, et al.
Pageof 10